You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: May 28, 2024

Details for Patent: 11,266,799

✉ Email this page to a colleague

« Back to Dashboard

Which drugs does patent 11,266,799 protect, and when does it expire?

Patent 11,266,799 protects TRUDHESA and is included in one NDA.

This patent has sixteen patent family members in thirteen countries.

Summary for Patent: 11,266,799

Title:	In-line nasal delivery device
Abstract:	A delivery device for a compound including: a housing, vial holding a compound; and a source of propellant, wherein the housing provides an inlet and an outlet for the vial, wherein the inlet is in fluid communication with the source of propellant and is directed against the in-line nasal delivery device compound and the outlet allows for delivery of the compound.
Inventor(s):	Fuller; Christopher (Seattle, WA), Hoekman; John D. (Seattle, WA), Kohring; Craig (Seattle, WA)
Assignee:	Impel Neuropharma, Inc. (Seattle, WA)
Application Number:	15/759,447
Patent Claim Types: see list of patent claims	Compound; Delivery; Device;

Drugs Protected by US Patent 11,266,799

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Jn Bidco	TRUDHESA	dihydroergotamine mesylate	SPRAY, METERED;NASAL	213436-001	Sep 2, 2021		RX	Yes	Yes	⤷ Sign Up	⤷ Sign Up	Y				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Patented / Exclusive Use	>Submissiondate

Foreign Priority and PCT Information for Patent: 11,266,799

PCT Information
PCT Filed	September 09, 2016	PCT Application Number:	PCT/US2016/051169
PCT Publication Date:	March 16, 2017	PCT Publication Number:	WO2017/044897

International Family Members for US Patent 11,266,799

Subscribe to access the full database, or Sign Up
Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Australia	2016321345	⤷ Sign Up
Canada	2998182	⤷ Sign Up
China	108601916	⤷ Sign Up
European Patent Office	3341059	⤷ Sign Up
Hong Kong	1252257	⤷ Sign Up
>Country	>Patent Number	>Estimated Expiration	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.